BridgeMD
New treatment option for Diabetes Mellitus, Type 2
Official title The Cardio-Metabolic Clinic
ClinicalTrials.gov ID: NCT06203860
What this study is testing
- What it's testing
- This study aims to investigate whether a Cardio-Metabolic Clinic can protect the cardiovascular health of patients with both diabetes and cardiovascular disease. At the Cardio-Metabolic Clinic, patients will receive a specialized and comprehensive care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Inclusion:
- \>18 years
- Capable of giving written informed consent
- Established diagnosis of T2D
- Having established heart or vascular disease defined as either:
See the full eligibility criteria
- Inclusion:
- \>18 years
- Capable of giving written informed consent
- Established diagnosis of T2D
- Having established heart or vascular disease defined as either:
- Atherosclerotic disease defined as:
- Prior acute coronary syndrome (ACS).
- Chronic coronary syndrome defined as the combination of: Angina pectoris AND coronary atherosclerosis assessed with either Coronary CT angiography (CTA) or Myocardial-scintigraphy (MPI) or Coronary angiography (CAG) AND...
- Stroke.
- Peripheral arterial disease (PAD) defined as: Claudication intermittence in combination with pathological ABI AND/OR vascular PAD surgery AND/OR ischemic amputation.
- Ischemic heart disease defined by one of the following criteria: a) Myocardial-scintigraphy: \>10% reversibility OR b) Coronary CT angiography: Coronary Artery Calcium (CAC)-score \>100.
- Heart failure (HF): HF with reduced ejection fraction (HFrEF), HF with Mildly reduced ejection fraction (HFmrEF), HF with preserved ejection fraction (HFpEF)
- Atrial fibrillation and/or flutter, including paroxysmal, persistent and chronic disease
- Valvular heart disease (which requires control in outpatient clinic of cardiology), such as aortic valve stenosis, mitral valve insufficiency, and patients with aortic dilatation
- Hypertension treated with at least three antihypertensive drugs Exclusion:
- Life expectancy less than 5 years for any reason
- Type 1 Diabetes Mellitus
- Participation in another clinical trial with an investigational product or device that could interfere with the primary and/or secondary endpoints of this study
The study team makes the final eligibility decision.
Where it's taking place
- Svendborg, Region Syddanmark, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Svendborg, Region Syddanmark, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.